68 research outputs found
Hospital mortality among major trauma victims admitted on weekends and evenings: a cohort study
Article deposited according to publisher policy posted on SHERPA/RoMEO, 14/09/2010.YesFunding provided by the Open Access Authors Fund
African-American crack abusers and drug treatment initiation: barriers and effects of a pretreatment intervention
BACKGROUND: Individual and sociocultural factors may pose significant barriers for drug abusers seeking treatment, particularly for African-American crack cocaine abusers. However, there is evidence that pretreatment interventions may reduce treatment initiation barriers. This study examined the effects of a pretreatment intervention designed to enhance treatment motivation, decrease crack use, and prepare crack abusers for treatment entry. METHODS: Using street outreach, 443 African-American crack users were recruited in North Carolina and randomly assigned to either the pretreatment intervention or control group. RESULTS: At 3-month follow-up, both groups significantly reduced their crack use but the intervention group participants were more likely to have initiated treatment. CONCLUSION: The intervention helped motivate change but structural barriers to treatment remained keeping actual admissions low. Policy makers may be interested in these pretreatment sites as an alternative to treatment for short term outcomes
Photosynthetic characteristics of a tropical population of Nitella cernua (Characeae, Chlorophyta)
Hepatic arterial infusional chemotherapy in the management of colorectal cancer liver metastases
‘Hospital-at-Night’ Expedites Review of Trauma Patients without Affecting Outcome from Hip Fracture
Organic Compounds as Indicators of Allochthonous and Autochthonous Input to Lake Sediments
A new 2CTAB/PCI method improves DNA amplification success from faeces of Mediterranean (Barbary macaques) and tropical (lowland gorillas) primates
Floxuridine Hepatic Arterial Infusion Associated Biliary Toxicity Is Increased by Concurrent Administration of Systemic Bevacizumab
- …